BioEcosse 2010
Characterisation of Biologics
Glasgow Science Centre
18th - 19th Jan 2010
Characterisation of Biologics 2010, Glasgow, Scotland
Scotland is the European hub of biosafety and characterisation testing for vaccines and biologics, with over 60% of all new drugs released in Europe being tested through labs in central Scotland. This conference is a focussed meeting, bringing together industry professionals who are involved in the testing and release of new biologic drugs and vaccines. Take advantage of this unique opportunity to discuss issues and experiences with key individuals in a location where biosafety testing actually occurs.
Featuring Guest Speakers:
CSO, BioReliance
"New techniques in QC Release Testing"
Dr. Onions is responsible for leading BioReliance's global scientific efforts across preclinical and clinical activities, including the development of enhanced assay systems, consulting with key customers and partnering with regulatory agencies. Dr. Onions joined BioReliance from Invitrogen Corporation where he has held the role of Chief Medical Officer since 2005.
Principal Scientist, Virology, NIBSC
"Rapid EU licensing procedures for pandemic vaccines"
Dr Jim Robertson is a Principal Scientist in Virology at the National Institute for Biological Standards and Control (NIBSC), a centre of the Health Protection Agency, UK. He is a core member of the Vaccine Working Party (VWP) of the European Medicines Agency (EMEA).
